These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 20367949)
21. Clinical contributions of exhaled volatile organic compounds in the diagnosis of lung cancer. Oguma T; Nagaoka T; Kurahashi M; Kobayashi N; Yamamori S; Tsuji C; Takiguchi H; Niimi K; Tomomatsu H; Tomomatsu K; Hayama N; Aoki T; Urano T; Magatani K; Takeda S; Abe T; Asano K PLoS One; 2017; 12(4):e0174802. PubMed ID: 28384298 [TBL] [Abstract][Full Text] [Related]
22. Detection of volatile organic compounds in exhaled breath to screen lung cancer: a systematic review. Hua Q; Zhu Y; Liu H Future Oncol; 2018 Jul; 14(16):1647-1662. PubMed ID: 29939068 [TBL] [Abstract][Full Text] [Related]
23. Volatile signature for the early diagnosis of lung cancer. Gasparri R; Santonico M; Valentini C; Sedda G; Borri A; Petrella F; Maisonneuve P; Pennazza G; D'Amico A; Di Natale C; Paolesse R; Spaggiari L J Breath Res; 2016 Feb; 10(1):016007. PubMed ID: 26857451 [TBL] [Abstract][Full Text] [Related]
24. A dual center study to compare breath volatile organic compounds from smokers and non-smokers with and without COPD. Gaida A; Holz O; Nell C; Schuchardt S; Lavae-Mokhtari B; Kruse L; Boas U; Langejuergen J; Allers M; Zimmermann S; Vogelmeier C; Koczulla AR; Hohlfeld JM J Breath Res; 2016 Apr; 10(2):026006. PubMed ID: 27082437 [TBL] [Abstract][Full Text] [Related]
25. Review of recent developments in determining volatile organic compounds in exhaled breath as biomarkers for lung cancer diagnosis. Zhou J; Huang ZA; Kumar U; Chen DDY Anal Chim Acta; 2017 Dec; 996():1-9. PubMed ID: 29137702 [TBL] [Abstract][Full Text] [Related]
26. Breath based volatile organic compounds in the detection of breast, lung, and colorectal cancers: A systematic review. Oakley-Girvan I; Davis SW Cancer Biomark; 2017 Dec; 21(1):29-39. PubMed ID: 29060925 [TBL] [Abstract][Full Text] [Related]
27. Noninvasive detection of lung cancer using exhaled breath. Fu XA; Li M; Knipp RJ; Nantz MH; Bousamra M Cancer Med; 2014 Feb; 3(1):174-81. PubMed ID: 24402867 [TBL] [Abstract][Full Text] [Related]
28. Organic metabolites in exhaled human breath--a multivariate approach for identification of biomarkers in lung disorders. Gaspar EM; Lucena AF; Duro da Costa J; Chaves das Neves H J Chromatogr A; 2009 Apr; 1216(14):2749-56. PubMed ID: 19036381 [TBL] [Abstract][Full Text] [Related]
29. Geographical variation in the exhaled volatile organic compounds. Amal H; Leja M; Broza YY; Tisch U; Funka K; Liepniece-Karele I; Skapars R; Xu ZQ; Liu H; Haick H J Breath Res; 2013 Dec; 7(4):047102. PubMed ID: 24184568 [TBL] [Abstract][Full Text] [Related]
30. Development of an Exhaled Breath Monitoring System with Semiconductive Gas Sensors, a Gas Condenser Unit, and Gas Chromatograph Columns. Itoh T; Miwa T; Tsuruta A; Akamatsu T; Izu N; Shin W; Park J; Hida T; Eda T; Setoguchi Y Sensors (Basel); 2016 Nov; 16(11):. PubMed ID: 27834896 [TBL] [Abstract][Full Text] [Related]
31. Noninvasive detection of colorectal cancer by analysis of exhaled breath. Wang C; Ke C; Wang X; Chi C; Guo L; Luo S; Guo Z; Xu G; Zhang F; Li E Anal Bioanal Chem; 2014 Jul; 406(19):4757-63. PubMed ID: 24820062 [TBL] [Abstract][Full Text] [Related]
32. Comparison of Targeted and Untargeted Approaches in Breath Analysis for the Discrimination of Lung Cancer from Benign Pulmonary Diseases and Healthy Persons. Koureas M; Kalompatsios D; Amoutzias GD; Hadjichristodoulou C; Gourgoulianis K; Tsakalof A Molecules; 2021 Apr; 26(9):. PubMed ID: 33946997 [TBL] [Abstract][Full Text] [Related]
33. Volatile organic compounds in exhaled breath: a promising approach for accurate differentiation of lung adenocarcinoma and squamous cell carcinoma. Li X; Shi L; Long Y; Wang C; Qian C; Li W; Tian Y; Duan Y J Breath Res; 2024 Aug; 18(4):. PubMed ID: 39019071 [TBL] [Abstract][Full Text] [Related]
34. Progress in the development of volatile exhaled breath signatures of lung cancer. Mazzone PJ; Wang XF; Lim S; Jett J; Choi H; Zhang Q; Beukemann M; Seeley M; Martino R; Rhodes P Ann Am Thorac Soc; 2015 May; 12(5):752-7. PubMed ID: 25965541 [TBL] [Abstract][Full Text] [Related]
35. Dependence of exhaled breath composition on exogenous factors, smoking habits and exposure to air pollutants. Filipiak W; Ruzsanyi V; Mochalski P; Filipiak A; Bajtarevic A; Ager C; Denz H; Hilbe W; Jamnig H; Hackl M; Dzien A; Amann A J Breath Res; 2012 Sep; 6(3):036008. PubMed ID: 22932429 [TBL] [Abstract][Full Text] [Related]
36. Blood volatile compounds as biomarkers for colorectal cancer. Wang C; Li P; Lian A; Sun B; Wang X; Guo L; Chi C; Liu S; Zhao W; Luo S; Guo Z; Zhang Y; Ke C; Ye G; Xu G; Zhang F; Li E Cancer Biol Ther; 2014 Feb; 15(2):200-6. PubMed ID: 24100612 [TBL] [Abstract][Full Text] [Related]
37. High sensitivity for lung cancer detection using analysis of exhaled carbonyl compounds. Schumer EM; Trivedi JR; van Berkel V; Black MC; Li M; Fu XA; Bousamra M J Thorac Cardiovasc Surg; 2015 Dec; 150(6):1517-22; discussion 1522-4. PubMed ID: 26412316 [TBL] [Abstract][Full Text] [Related]
38. Exhaled biomarkers in lung cancer. Horváth I; Lázár Z; Gyulai N; Kollai M; Losonczy G Eur Respir J; 2009 Jul; 34(1):261-75. PubMed ID: 19567608 [TBL] [Abstract][Full Text] [Related]